Pharmaceuticals, Policy and Law

Show Articles
Journal Properties
  • Language
    English
  • Number of Articles
    266
  • ISSN
    1389-2827
  • Main Publisher
    IOS Press
  • Publisher
    IOS Press
  • Indian UGC
  • DOAJ (latest)
Description
Exploring the intersection of pharmaceuticals, policy, and law, this journal provides a critical forum for research and analysis in the health sector. It examines how pharmaceutical regulations, policies, and legal frameworks impact access to medicines, drug development, and public health outcomes. The first 150 characters gives a summary of the journals focus. Pharmaceuticals, Policy and Law is a key platform for understanding this ever-evolving field. The journal covers a broad range of topics, including pharmaceutical pricing and reimbursement, intellectual property rights, drug safety and regulation, and the ethical considerations surrounding pharmaceutical use. It is indexed in databases such as Scopus, providing wide visibility to researchers and policymakers. Its target audience includes pharmacologists, health economists, legal scholars, and public health professionals who study the interplay between pharmaceuticals, policy, and legal systems. Submit your impactful research on pharmaceutical policy and legal issues to contribute to the global conversation. The journal aims to drive evidence-based policy decisions and promote equitable access to essential medicines. By publishing in this journal, researchers can influence the future of pharmaceutical regulation and improve healthcare delivery worldwide. It emphasizes on pharmaceutical and global health policy. The journal is not open access.